I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.

In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?

Anders Mortin is a seasoned eClinical professional with over two decades of experience in Clinical Development processes and systems.

Known for his strategic vision and leadership, Anders excels in managing cross-functional teams and driving innovative solutions.

As a co-founder of the Copenhagen-based pharma consulting firm, TriTiCon, established in 2015, he has been instrumental in shaping the company's success.

Anders holds a Master's degree in Engineering Physics from Lund University in Sweden and has been a key player in the industry since the early 90’s.

His extensive background in business, data, and project management has provided a solid foundation for TriTiCon's diverse services.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.

In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?

Belma Alispahic, Co-Founder and Chief Scientific Officer of AnalysisMode.

With a Master’s in Applied Biotechnology from Uppsala University and a track record of turning complexity into clarity, Belma is reshaping how we think about bioprocess development.

At AnalysisMode, she leads the charge behind SimCell, an AI-powered platform designed to accelerate bioprocess efficiency, reduce time-to-market, and future-proof pharmaceutical workflows.

Belma recently took the stage at the 9th Bioproduction Congress (BIOPC 2024) in France, where she shared her insights on “Future-Proofing with AI-Powered Bioprocess Development.” Her message was clear: AI isn’t optional—it’s essential for navigating the increasingly complex biopharma landscape.

This isn’t just about algorithms—it’s about empowering scientists to make smarter decisions, faster. Belma’s work is a testament to what happens when deep scientific expertise meets bold technological vision.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.

In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?

At the helm of Delve Health, Wessam Sonbol is driving a revolution in decentralized and hybrid clinical trials. His platform supports studies in over 65 languages, enabling inclusive research across continents.

By integrating wearables, TeleVisits, and AI-driven tools, Delve Health has helped sponsors reduce patient dropout rates by up to 30% and accelerate trial timelines by 20%.

Wessam’s leadership spans more than 25 years in clinical research and healthcare technology. He’s managed complex Phase I–IV and 510(k) trials for global giants like Medtronic, Abbott Vascular, and Johnson & Johnson. His entrepreneurial journey includes founding Clinical Systems Consultants—scaling it across three continents—and developing platforms that achieved multi-million dollar exits.

Inspired by personal experience, Wessam is fiercely committed to patient-centricity. His innovations simplify trial access and elevate outcomes. He also co-developed Perta.io, a data mining platform that connects clinical trials, publications, and drug pipelines using AI and NLP—cutting research time by up to 40% for scientists and sponsors.

Whether it’s through founding companies or building ecosystems, Wessam doesn’t just follow the pulse of clinical research. He shapes it.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.

In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?

In this episode, we sit down with Philip Morisky, Chief Optimus at Adherence, to explore the missing metric in healthcare: medication adherence.

Building on the legacy of the Morisky Medication Adherence Scale (MMAS), Philip shares how he's transforming behavioral diagnostics into actionable insights—bridging the gap between validated measurement and real-world impact. From the evolution of MMAS-8R to the launch of ATLAS™, we unpack how fidelity, training, and data intelligence are reshaping global standards in patient care.

Welcome to the Pharma Prescribed podcast

I’m Adam Walker a Biometrics consultant looking to uncover the real stories behind life science leaders in clinical research.

Today, we have the honour of hosting Yuriy Lebid, the dynamic CEO of Pharmaxi, a leading contract research organization based in Ukraine.

Yuriy's journey is nothing short of inspiring. Since the onset of the conflict on February 24, 2022, he has not only persevered but has continued to lead and innovate in the face of adversity.

Pharmaxi LLC is a Contract Research Organization (CRO) with a keen focus on the regions of Ukraine and Poland. The organization offers a comprehensive range of services in the realm of clinical trials, with an emphasis on regulatory affairs, clinical monitoring, and data management.

Join us as we delve into Yuriy's remarkable story, exploring what drew him to the life sciences industry and how he has navigated the challenges to drive Pharmaxi's success.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.”

“In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?

Our guest today is Charbel Abdo.

Born and raised in Lebanon, Charbel brings deep-rooted expertise and a global perspective to the future of pharmaceutical care. A fully qualified pharmacist, he built his clinical foundation in Lebanon and recently earned his MSc in Pharmaceutical Sciences—with distinction—at the University of Greenwich.

Now based in the UK, Charbel is actively seeking his first opportunity in clinical research. With a passion for evidence-based practice and an eye for regulatory innovation, he’s ready to bring analytical precision and patient-first thinking to a forward-looking clinical trials team.

He blends frontline experience with academic depth and is eager to step into the UK clinical research space, where he can apply scientific background and multicultural insight to make meaningful contributions to patient safety and trial excellence.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.

In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?

Our guest today is Matthew Mace.

He is redefining what leadership looks like at the cutting edge of clinical research on multiple fronts.

Founder of Study Connect Inc., where he’s on a mission to streamline scientific innovation through faster trials and smarter collaboration. He’s not just building a platform—he’s shaping a movement.

You might also know him as the host of the Study Success podcast, where he amplifies bold ideas and practical strategies driving real progress in our industry.

And now, as a newly appointed Board Director at Precision Cardiovascular, he’s bringing his deep expertise in cardiac innovation to a company creating the next generation of monitoring tech.

Previously, as Co-Founder and CSO at Acorai, Matthew led the largest hemodynamic study in heart failure history, secured FDA Breakthrough Device Designation, and raised over $10 million to bring a novel technology to market.

With over 15 years across cardiology, AI, and medtech—plus a knack for turning vision into impact—Matthew brings unmatched perspective, purpose, and drive.

He is passionate about new technologies and exploring the boundaries to continue the evolution of patient care.

His aim is to further enhance the reach of lifesaving technology into the hands of healthcare professionals for the benefit of patients.

Welcome to the Pharma Prescribed podcast.

I’m Adam Walker a Biometrics consultant looking to uncover the real stories behind life science leaders in clinical research.

Today’s guest is Charlotte Chadwick, CEO of Clinology - Making consultants more visible in Pharma and Biotech.

The central "why" lies in a commitment to impactful dialogues that highlight collaboration, innovation, and ethical practices.